Proteinase-activated receptors:: novel mechanisms of signaling by serine proteases

被引:686
作者
Déry, O [1 ]
Corvera, CU
Steinhoff, M
Bunnett, NW
机构
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 1998年 / 274卷 / 06期
关键词
G protein-coupled receptors; thrombin; trypsin;
D O I
10.1152/ajpcell.1998.274.6.C1429
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although serine proteases are usually considered to act principally as degradative enzymes, certain proteases are signaling molecules that specifically regulate cells by cleaving and triggering members of a new family of proteinase-activated receptors (PARs). There are three members of this family, PAR-1 and PAR-3, which are receptors for thrombin, and PAR-2, a receptor for trypsin and mast cell tryptase. Proteases cleave within the extracellular NH2-terminus of their receptors to expose a new NH2-terminus. Specific residues within this tethered ligand domain interact with extracellular domains of the cleaved receptor, resulting in activation. In common with many G protein-coupled receptors, PARs couple to multiple G proteins and thereby activate many parallel mechanisms of signal transduction. PARs are expressed in multiple tissues by a wide variety of cells, where they are involved in several pathophysiological processes, including growth and development, mitogenesis, and inflammation. Because the cleaved receptor is physically coupled to its agonist, efficient mechanisms exist to terminate signaling and prevent uncontrolled stimulation. These include cleavage of the tethered ligand, receptor phosphorylation and uncoupling from G proteins, and endocytosis and lysosomal degradation of activated receptors.
引用
收藏
页码:C1429 / C1452
页数:24
相关论文
共 166 条
  • [61] Hollenberg MD, 1996, MOL PHARMACOL, V49, P229
  • [62] HOLLENBERG MD, 1993, MOL PHARMACOL, V43, P921
  • [63] Protease-mediated signalling: New paradigms for cell regulation and drug development
    Hollenberg, MD
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (01) : 3 - 6
  • [64] HORVAT R, 1995, J CELL SCI, V108, P1155
  • [65] PERIPHERAL-BLOOD LYMPHOCYTES EXPRESS THE PLATELET-TYPE THROMBIN RECEPTOR
    HOWELLS, GL
    MACEY, M
    CURTIS, MA
    STONE, SR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (01) : 156 - 160
  • [66] Howells GL, 1997, J CELL SCI, V110, P881
  • [67] HOXIE JA, 1993, J BIOL CHEM, V268, P13756
  • [68] HUNG DT, 1992, J BIOL CHEM, V267, P20831
  • [69] CLONED PLATELET THROMBIN RECEPTOR IS NECESSARY FOR THROMBIN-INDUCED PLATELET ACTIVATION
    HUNG, DT
    VU, TKH
    WHEATON, VI
    ISHII, K
    COUGHLIN, SR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) : 1350 - 1353
  • [70] Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells
    Hwa, JJ
    Ghibaudi, L
    Williams, P
    Chintala, M
    Zhang, RM
    Chatterjee, M
    Sybertz, E
    [J]. CIRCULATION RESEARCH, 1996, 78 (04) : 581 - 588